Background/Objectives: A high-calorie diet contributes to the development of metabolic dysfunction-associated steatotic liver disease (MASLD). Excessive saturated fat intake can lead to metabolic dysfunction, depending on the sources, quality, and duration of the oils and fats consumed. Palmolein, ghee, and coconut oil are common dietary fats that differ in SFA content. The long-term relative metabolic effects of these fats on hepatic steatosis are limited. Methods: Forty adult male C57BL/6 mice were divided into five groups (n=8): chow diet (5% peanut oil) and high-fat (HF) diet (all 25% w/w) enriched with peanut, palmolein, ghee, and coconut oil. All the HF groups are isocaloric and receive 58.4% of their energy from fat. Results: After 6 months, body weight gain and fasting glucose were elevated in all HF groups (p<0.05), except in the peanut-fed group. Ghee-fed mice showed the highest feed efficiency, visceral adiposity, insulin resistance, plasma TG, leptin, liver TG, fatty liver score, IL-6 expression, and malondialdehyde levels (p<0.05). Unlike ghee, coconut oil-fed mice exhibited insulin resistance, hepatic lipid accumulation, and IL-6 expression (p<0.05), independent of visceral adiposity and oxidative stress. Palmolein oil-fed groups showed minimal changes in fatty liver score (p>0.05) compared with ghee- and coconut oil-fed groups. Conclusions: Long-term intake of ghee- and coconut oil-enriched diets induces mild microvesicular steatosis and inflammation in the liver compared with the peanut and palmolein diets by triggering insulin resistance and dyslipidemia. The protective effects of palmolein may be due to its tocotrienols, which are known to have hypolipidemic, antioxidant and anti-inflammatory properties.